Citations to this article

Dendritic cells: at the clinical crossroads
James J. Mulé
James J. Mulé
Published March 15, 2000
Citation Information: J Clin Invest. 2000;105(6):707-708. https://doi.org/10.1172/JCI9591.
View: Text | PDF
Commentary

Dendritic cells: at the clinical crossroads

Abstract

Authors

James J. Mulé

×

Total citations by year

Year: 2021 2020 2013 2010 2009 2005 2004 2003 2002 2001 1983 Total
Citations: 1 1 1 1 4 1 1 1 3 6 1 21
Citation information

Citations to this article (21)

Title and authors Publication Year
Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle
US Kumar, R Afjei, K Ferrara, TF Massoud, R Paulmurugan 		ACS Nano 2021
Stem cell factor produced by tumor cells expands myeloid-derived suppressor cells in mice
WC Lee, PY Hsu, HY Hsu 		Scientific Reports 2020
IL4 and IFNalpha generation of dendritic cells reveals great migratory potential and NFkB and cJun expression in IL4DCs
MT de Azevedo, ST Saad, SC Gilli 		Immunological Investigations 2013
Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity
N Matsushita, H Komine, A Grolleau-Julius, S Pilon-Thomas, JJ Mulé 		Cancer Immunology, Immunotherapy 2010
Specifically activated dendritic cells—Cell-based vaccine against lymphosarcoma exhibiting multiple drug resistance phenotype
NL Mironova, EE Panzinskyi, NA Popova, VP Nikolin, MA Zenkova, VV Vlasov 		Doklady Biochemistry and Biophysics 2009
Dendritic Cell-Based Vaccines for Pancreatic Cancer and Melanoma
JJ Mulé 		Annals of the New York Academy of Sciences 2009
Komórki dendrytyczne w tkance przerosłych migdałków gardłowych u dzieci chorych na wysiękowe zapalenie ucha środkowego
B Żelazowska-Rutkowska, K Ratomski, J Wysocka, E Kasprzycka, E Hassmann-Poznańska, M Mrugacz 		Otolaryngologia Polska 2009
Rapid Assay of Trace Ceruloplasmin Using an Immunonanogold Resonance Scattering Spectral Probe
Z JIANG, L WEI, A LIANG 		Analytical Sciences 2009
Chemo-Immunotherapy of Breast Cancer Using Vesiculated α-Tocopheryl Succinate in Combination With Dendritic Cell Vaccination
LV Ramanathapuram, T Hahn, SM Dial, ET Akporiaye 		Nutrition and Cancer 2005
Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F 		Cancer Immunology, Immunotherapy 2004
Enhancing dendritic cell-based vaccines by gene modification
Alicia Terando, James J Mulé 		Blood cells, molecules & diseases 2003
Immunological weapons against acute myeloid leukaemia
J Galea-Lauri 		Immunology 2002
M-Vax: an autologous, hapten-modified vaccine for human cancer
D Berd 		Expert Opinion on Biological Therapy 2002
S-100 Protein+ Dendritic Cells and CD34+ Dendritic Interstitial Cells in Thyroid Lesions
A Batistatou, V Zolota, CD Scopa 		Endocrine Pathology 2002
STRATEGIES FOR DESIGNING AND OPTIMIZING NEW GENERATION VACCINES
JA Berzofsky, JD Ahlers, IM Belyakov 		Nature Reviews Immunology 2001
Dendritic cell vaccines for cancer therapy
GM Sprinzl, L Kacani, A Schrott-Fischer, N Romani, WF Thumfart 		Cancer Treatment Reviews 2001
Challenges to the development of antigen-specific breast cancer vaccines
MJ Scanlan, D Jäger 		Breast Cancer Research 2001
Generation of CD4+ and CD8+ T Lymphocyte Responses by Dendritic Cells Armed with PSA/Anti-PSA (Antigen/Antibody) Complexes
KA Berlyn, B Schultes, B Leveugle, AA Noujaim, RB Alexander, DL Mann 		Clinical Immunology 2001
INDUCTION OF T CELL RESPONSES AGAINST AUTOLOGOUS OVARIAN TUMORS WITH WHOLE TUMOR CELL LYSATE-PULSED DENDRITIC CELLS
X Zhao, Y Wei, Z Peng 		Immunological Investigations 2001
Challenges to the development of antigen-specific breast cancer vaccines
MJ Scanlan, D Jäger 		Breast Cancer Research 2001
Progress in Brain Research
DE van Epps, L Saland, C Taylor, RC Williams 		Progress in brain research 1983

Advertisement